Jump to content

Drilldown: Medicines

Nav

Choose a table:

Medicines (732)

Medicines > fda max: 50 mg BID in heart failure (or once-daily equivalent CR); 25 mg BID in hypertension

& routes

: Oral

or intranasal

Use the filters below to narrow your results.

Coreg, Coreg CR (1)

with alpha-1 antagonism)]] (1) · [[:Category:Antihypertensives|Antihypertensive]] (1) · [[:Category:Beta blockers|Beta blocker (non-selective (1) · [[:Category:Heart failure medicines|Heart failure medicine]] (1)

'"`UNIQ--vote-00000015-QINU`"' CYP2D6 metabolism produces stereoselective clearance; CYP2D6 poor metabolizers have higher plasma exposure and may need lower doses'"`UNIQ--ref-00000016-QINU`"'. (1)

'"`UNIQ--vote-00000017-QINU`"', '"`UNIQ--vote-00000018-QINU`"', '"`UNIQ--vote-00000019-QINU`"', '"`UNIQ--vote-0000001A-QINU`"' (1)

Heart failure: 3.125 mg PO BID, doubling every 2 weeks as tolerated to target 25 mg BID (50 mg BID if >85 kg). Hypertension: 6.25 mg PO BID, titrate to 25 mg BID (1)

IR tablets 3.125, 6.25, 12.5, 25 mg; Coreg CR capsules 10, 20, 40, 80 mg (once-daily) (1)

Antihypertensive effect within 1 week; heart-failure mortality benefit accrues over months of titration (1)

~12 hours (IR); 24 hours (CR) (1)

7-10 hours'"`UNIQ--ref-0000001B-QINU`"' (1)

~25-35% (extensive first-pass), increased by food which slows absorption and reduces orthostatic risk'"`UNIQ--ref-0000001C-QINU`"' (1)

Limited human data; β-blocker class effects include fetal growth restriction and neonatal bradycardia/hypoglycemia.<sup class="pcp-cn" title="This claim needs a citation.">[[[Pharmacopedia:Citation needed|citation needed]]]</sup> (1)

[[USLegal:Prescription only|Rx-only]] in US (1)

Showing below up to 1 result in range #1 to #1.

C

Carvedilol

Retrieved from "https://pharmacopedia.wiki/p/Special:Drilldown/Medicines"